MHUA
Income statement / Annual
Last year (2024), Meihua International Medical Technologies Co., Ltd.'s total revenue was $96.91 M,
a decrease of 0.19% from the previous year.
In 2024, Meihua International Medical Technologies Co., Ltd.'s net income was $10.84 M.
See Meihua International Medical Technologies Co., Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$96.91 M |
$97.10 M |
$103.35 M |
$104.04 M |
$89.06 M |
$79.63 M |
$75.71 M |
| Cost of Revenue |
$63.61 M
|
$64.00 M
|
$65.25 M
|
$64.23 M
|
$51.90 M
|
$47.42 M
|
$43.82 M
|
| Gross Profit |
$33.30 M
|
$33.10 M
|
$38.10 M
|
$39.81 M
|
$37.16 M
|
$32.21 M
|
$31.89 M
|
| Gross Profit Ratio |
0.34
|
0.34
|
0.37
|
0.38
|
0.42
|
0.4
|
0.42
|
| Research and Development Expenses |
$3.46 M
|
$2.75 M
|
$2.96 M
|
$2.73 M
|
$2.49 M
|
$3.21 M
|
$2.87 M
|
| General & Administrative Expenses |
$8.25 M
|
$7.82 M
|
$13.04 M
|
$5.32 M
|
$3.71 M
|
$3.28 M
|
$4.16 M
|
| Selling & Marketing Expenses |
$5.27 M
|
$5.15 M
|
$7.11 M
|
$6.46 M
|
$6.62 M
|
$5.41 M
|
$5.67 M
|
| Selling, General & Administrative Expenses |
$13.52 M
|
$12.97 M
|
$18.68 M
|
$11.78 M
|
$10.34 M
|
$8.68 M
|
$9.85 M
|
| Other Expenses |
$2.01 M
|
$2.70 M
|
$898.66 K
|
$0.00
|
$864.79 K
|
$926.20 K
|
$0.00
|
| Operating Expenses |
$18.99 M
|
$18.42 M
|
$22.54 M
|
$14.50 M
|
$13.69 M
|
$12.82 M
|
$13.10 M
|
| Cost And Expenses |
$82.60 M
|
$82.42 M
|
$92.54 M
|
$78.74 M
|
$65.59 M
|
$60.24 M
|
$56.92 M
|
| Interest Income |
$1.01 M
|
$873.44 K
|
$63.73 K
|
$23.86 K
|
$36.58 K
|
$48.84 K
|
$77.42 K
|
| Interest Expense |
$1.51 M
|
$250.78 K
|
$194.67 K
|
$180.74 K
|
$137.16 K
|
$97.79 K
|
$0.00
|
| Depreciation & Amortization |
$571.04 K
|
$470.99 K
|
$563.46 K
|
$622.47 K
|
$523.43 K
|
$509.22 K
|
$567.77 K
|
| EBITDA |
$15.70 M |
$15.77 M |
$11.65 M |
$27.03 M |
$24.39 M |
$19.90 M |
$19.74 M |
| EBITDA Ratio |
0.16
|
0.16
|
0.11
|
0.26
|
0.27
|
0.25
|
0.26
|
| Operating Income Ratio |
0.15
|
0.15
|
0.1
|
0.25
|
0.26
|
0.24
|
0.25
|
| Total Other Income/Expenses Net |
-$685.78 K
|
$373.84 K
|
$89.29 K
|
-$32.91 K
|
$267.35 K
|
-$137.69 K
|
-$465.98 K
|
| Income Before Tax |
$13.63 M
|
$15.05 M
|
$10.89 M
|
$26.23 M
|
$23.73 M
|
$19.25 M
|
$18.71 M
|
| Income Before Tax Ratio |
0.14
|
0.15
|
0.11
|
0.25
|
0.27
|
0.24
|
0.25
|
| Income Tax Expense |
$2.79 M
|
$3.46 M
|
$4.71 M
|
$5.28 M
|
$4.69 M
|
$3.82 M
|
$3.23 M
|
| Net Income |
$10.84 M
|
$11.63 M
|
$6.24 M
|
$20.95 M
|
$19.05 M
|
$15.43 M
|
$15.48 M
|
| Net Income Ratio |
0.11
|
0.12
|
0.06
|
0.2
|
0.21
|
0.19
|
0.2
|
| EPS |
40 |
49 |
27 |
89 |
79 |
64 |
77 |
| EPS Diluted |
40 |
49 |
27 |
89 |
79 |
64 |
77 |
| Weighted Average Shares Out |
$273.72 K
|
$239.40 K
|
$234.11 K
|
$236.00 K
|
$241.40 K
|
$241.40 K
|
$200.00 K
|
| Weighted Average Shares Out Diluted |
$273.72 K
|
$239.40 K
|
$234.11 K
|
$236.00 K
|
$241.40 K
|
$241.40 K
|
$200.00 K
|
| Link |
|
|
|
|
|
|
|
